@article{8528f90ce5224d5b92a553ddc761b238,
title = "Editorial: Interferons and GvHD",
keywords = "CD27, CD70, GvHD, JAK - STAT signaling pathway, JAK inhibitors, LYG1, allogeneic hematopoietic cell transplant (alloHCT), interferons",
author = "Boram Kim and Jaebok Choi",
note = "Funding Information: JC is supported by Emerson Collective, NIH/NIAID (R21 AI155990), the Alvin J. Siteman Cancer Center through The Foundation for Barnes-Jewish Hospital, and the Alvin J. Siteman Cancer Center through The Foundation for Barnes-Jewish Hospital and the National Cancer Institute (P30 CA091842). Funding Information: Conflict of Interest: JC received an honorarium from Incyte Corporation and research funding from Mallinckrodt Pharmaceuticals.",
year = "2022",
month = feb,
day = "3",
doi = "10.3389/fimmu.2022.853567",
language = "English",
volume = "13",
journal = "Frontiers in immunology",
issn = "1664-3224",
}